急性心肌梗死合并心脏破裂患者24小时内死亡风险的超声心动图指标预测模型的建立与验证
该回顾性研究纳入2020年6月至2025年6月中南大学湘雅三医院收治的76例急性心肌梗死合并心脏破裂患者,按诊断后24小时内是否死亡分为死亡组(50例)与存活组(26例),比较两组超声心动图参数。多因素Logistic回归显示,大量心包积液(OR=6.995,95%CI 1.102-44.396,P=0.039)和左室舒张末径升高(OR=1.188,95%CI 1.032-1.369,P=0.017)是24小时内死亡的危险因素,每搏输出量升高为保护因素(OR=0.926,95%CI 0.867-0.989,P=0.022)。基于上述三项指标构建的预测模型AUC为0.894(95%CI 0.817-0.955),最佳截断值0.555时敏感度86.0%、特异度84.6%;内部验证AUC为0.899(95%CI 0.814-0.962),最佳截断值0.638时敏感度83.7%、特异度90.7%。校准曲线和临床决策曲线分析提示模型一致性和净获益良好。
要点
- 急性心肌梗死合并心脏破裂患者中,大量心包积液者24小时内死亡风险约为无大量心包积液者的6.995倍(OR=6.995,95%CI 1.102-44.396,P=0.039)。
- 左室舒张末径每增加1 mm,24小时内死亡风险升高(OR=1.188,95%CI 1.032-1.369,P=0.017);每搏输出量升高为保护因素(OR=0.926,95%CI 0.867-0.989,P=0.022)。
- 基于左室舒张末径、每搏输出量和大量心包积液构建的预测模型AUC为0.894(95%CI 0.817-0.955),最佳截断值0.555时敏感度86.0%、特异度84.6%。
- 内部验证(Bootstrap 1000次重抽样)AUC为0.899(95%CI 0.814-0.962),最佳截断值0.638时敏感度83.7%、特异度90.7%。
- 死亡组与存活组在右房径、右室径、主动脉瓣反流程度、二尖瓣反流程度、三尖瓣反流程度、室壁瘤比例及前壁节段性室壁运动异常比例方面差异均无统计学意义(均P>0.05)。
适用人群与场景
- 2020年6月至2025年6月中南大学湘雅三医院收治的诊断为急性心肌梗死合并心脏破裂的患者。
- 共纳入76例,其中男性54例(71%)、女性22例(29%),中位年龄64(56,68)岁。
诊断标准与关键阈值
- 预测模型基于左室舒张末径、每搏输出量和大量心包积液三项超声心动图指标构建,以列线图呈现。
- 模型预测概率最佳截断值:建模队列为0.555(敏感度86.0%、特异度84.6%),内部验证队列为0.638(敏感度83.7%、特异度90.7%)。
研究设计与关键结果
- 回顾性分析纳入76例急性心肌梗死合并心脏破裂患者,死亡组50例、存活组26例;死亡组男性比例高于存活组(80% vs. 54%,P<0.05),两组年龄差异无统计学意义(P>0.05)。
- 死亡组左房径大于存活组[39(35,43)mm vs. 33(31,37)mm],左室舒张末径大于存活组[59(54,64)mm vs. 48(45,54)mm],大量心包积液比例高于存活组(36% vs. 8%),差异均有统计学意义(均P<0.05)。
- 死亡组左室射血分数低于存活组[0.39(0.31,0.50)vs. 0.53(0.45,0.58)],每搏输出量低于存活组[40(30,52)mL vs. 55(49,67)mL],差异均有统计学意义(均P<0.05)。
- 多因素Logistic回归显示大量心包积液(OR=6.995,95%CI 1.102-44.396,P=0.039)和左室舒张末径升高(OR=1.188,95%CI 1.032-1.369,P=0.017)为24小时内死亡的危险因素,每搏输出量升高为保护因素(OR=0.926,95%CI 0.867-0.989,P=0.022)。
- 预测模型ROC曲线AUC为0.894(95%CI 0.817-0.955),最佳截断值0.555时敏感度86.0%、特异度84.6%;Bootstrap 1000次重抽样内部验证AUC为0.899(95%CI 0.814-0.962),最佳截断值0.638时敏感度83.7%、特异度90.7%。
- 校准曲线和临床决策曲线分析提示模型一致性和净获益良好。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于超声心动图参数的风险预测模型对急性心肌梗死合并心脏破裂患者24小时内死亡风险具有一定预测价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the risk factors of death within 24 hours in patients with acute myocardial infarction (AMI) complicated by cardiac rupture in echocardiographic indicators, build a risk prediction model and explore its prediction efficiency.
METHODS: A retrospective analysis was conducted. Echocardiographic data of patients diagnosed with AMI complicated by cardiac rupture admitted to Xiangya Third Hospital of Central South University from June 2020 to June 2025 were enrolled. Patients were divided into survival group and death group based on whether they died within 24 hours after diagnosis. Echocardiographic parameters were compared between the two groups. Multivariate Logistic regression analysis was performed to identify factors associated with death within 24 hours. Based on these findings, a risk prediction model was established and presented as a nomogram. The discriminative ability of the model was evaluated using the receiver operator characteristic curve (ROC curve). The Bootstrap method with 1 000 resampling iterations was used for internal validation. The predictive performance and clinical applicability of the model were comprehensively assessed by integrating the ROC curve, calibration curve, and decision curve analysis.
RESULTS: A total of 76 patients were included, comprising 54 males (71%) and 22 females (29%), with a median age of 64 (56, 68) years old. There were 50 patients in the death group and 26 patients in the survival group. The proportion of males was higher in the death group than in the survival group (80% vs. 54%, P<0.05), while there was no difference in age between the two groups (P>0.05). In the echocardiographic parameters, the death group showed larger left atrial diameter (LAD), left ventricular end-diastolic diameter (LVEDD), and a higher proportion of massive pericardial effusion compared with the survival group [LAD (mm): 39 (35, 43) vs. 33 (31, 37), LVEDD (mm): 59 (54, 64) vs. 48 (45, 54), massive pericardial effusion: 36% vs. 8%], left ventricular ejection fraction (LVEF) and stroke volume (SV) were lower in the death group than in the survival group [LVEF: 0.39 (0.31, 0.50) vs. 0.53 (0.45, 0.58), SV (mL): 40 (30, 52) vs. 55 (49, 67)], with all differences being statistically significant (all P<0.05). There were no significant differences in right atrial diameter, right ventricular diameter, severity of aortic regurgitation, mitral regurgitation, tricuspid regurgitation, and the proportions of ventricular aneurysm and anterior wall segmental wall motion abnormalities between the two groups (all P>0.05). Multivariate Logistic regression analysis showed that massive pericardial effusion [odds ratio (OR)=6.995, 95% confidence interval (95%CI) was 1.102-44.396, P=0.039] and elevated LVEDD (OR=1.188, 95%CI was 1.032-1.369, P=0.017) were risk factors for death within 24 hours in patients with AMI complicated by cardiac rupture, elevated SV was a protective factor against death within 24 hours in these patients (OR=0.926, 95%CI was 0.867-0.989, P=0.022). A prediction model was constructed using LVEDD, SV, and massive pericardial effusion. The area under the ROC curve (AUC) was 0.894 (95%CI was 0.817-0.955), and the sensitivity was 86.0% and specificity was 84.6% when the optimal cut-off value was 0.555. The internally validated model achieved an AUC of 0.899 (95%CI was 0.814-0.962), and the sensitivity was 83.7% and specificity was 90.7% when the optimal cut-off value was 0.638. Calibration curve and clinical decision curve analysis indicated good model consistency and net benefit.
CONCLUSIONS: The risk prediction model based on echocardiographic parameters has certain predictive value for the risk of death within 24 hours in patients with AMI complicated by cardiac rupture.
参考来源
- Feng W, Hu W, Zeng M, et al. [Establishment and validation of echocardiographic index prediction model for mortality risk within 24 hours in patients with acute myocardial infarction complicated with cardiac rupture]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42281539. doi:10.3760/cma.j.cn121430-20251129-00573
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。